Related Experiment Video
Updated: Jan 17, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Exploring Macrophage Contribution to Vascular Calcification in Atherosclerosis
Siarhei A Dabravolski1, Mikhail A Popov2, Olga N Maltseva3
1Department of Biotechnology Engineering, Braude Academic College of Engineering, Karmiel, Israel.
Insights
Macrophages play a dual role in vascular calcification (VC), a key feature of atherosclerosis. Understanding their M1 and M2 phenotypes offers new therapeutic targets for cardiovascular disease, especially in diabetes and CKD.
Area of Science:
- Cardiovascular Biology
- Immunology
- Pathology
Background:
- Vascular calcification (VC) is a critical factor in atherosclerosis, increasing cardiovascular morbidity and mortality.
- VC is particularly prevalent in patients with diabetes and chronic kidney disease (CKD).
- Macrophages are key cellular players in the development and progression of VC within atherosclerotic plaques.
Purpose of the Study:
- To review the pivotal role of macrophages in vascular calcification (VC).
- To explore the distinct functions of M1 and M2 macrophage phenotypes in modulating vascular smooth muscle cell (VSMC) behavior and calcification.
- To highlight microRNAs (miRNAs) as potential therapeutic targets for regulating macrophage activation in VC.
Main Methods:
- Literature review focusing on macrophage phenotypes (M1 and M2) and their functions in VC.
- Analysis of cellular and molecular mechanisms of macrophage-mediated calcification.
- Examination of the influence of macrophage balance on osteoclastic differentiation and calcified deposit resorption.
Main Results:
- M1 macrophages promote VSMC transdifferentiation and calcification via pro-inflammatory cytokines (e.g., OSM, BMP).
- M2 macrophages exhibit protective effects that may mitigate excessive vascular calcification.
- The balance of macrophage populations influences osteoclastic differentiation and the resorption of calcified deposits.
Conclusions:
- Macrophages have dual roles in atherosclerosis-related VC, acting as both promoters and potential mitigators.
- Understanding macrophage phenotypes and their regulation by miRNAs is crucial for developing novel therapeutic strategies.
- Targeting macrophage pathways could improve cardiovascular health outcomes, especially in high-risk populations like those with diabetes and CKD.
Abstract:
Vascular calcification (VC) is a significant pathological feature of atherosclerosis, contributing to cardiovascular morbidity and mortality, particularly in populations with diabetes and chronic kidney disease (CKD). This review examines the pivotal role of macrophages in the development and progression of VC within atherosclerotic plaques. We explore the diverse phenotypes of macrophages, particularly the pro-inflammatory M1 and anti-inflammatory M2 types, and their distinct functions in modulating vascular smooth muscle cell (VSMC) behavior. M1 macrophages promote osteogenic signaling through the secretion of pro-inflammatory cytokines and growth factors, such as oncostatin M (OSM) and bone morphogenetic proteins (BMP), which facilitate VSMC transdifferentiation and calcification. Conversely, M2 macrophages exhibit protective properties that may mitigate excessive calcification. Furthermore, we discuss the intricate balance of these macrophage populations in atherosclerotic lesions and their influence on osteoclastic differentiation, which can either enhance or inhibit the resorption of calcified deposits. Recent findings on the involvement of microRNAs (miRNAs) in regulating macrophage activation and their impact on VC highlight potential therapeutic targets for mitigating this process. By elucidating the cellular and molecular mechanisms underpinning macrophage-mediated calcification, this review aims to provide insights into the dual roles of macrophages in atherosclerosis and their significance as potential therapeutic targets. Understanding these dynamics may lead to innovative strategies for preventing VC and improving cardiovascular health outcomes, particularly in patients with diabetes and CKD.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction

